Clinical Trial

Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A Phase 4, multi-center, open-label, single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) study of Testosterone Cypionate Injection in Hypogonadal Men to assess change in 24-hour ambulatory blood pressure from Baseline to End of Treatment
Trial Details
NCT Number NCT07328542
Lead Sponsor Azurity Pharmaceuticals
Collaborators: CBCC Global Research
Conditions Hypogonadism, Male
Enrollment 144 participants
Start Date 2026-02
Primary Completion 2027-06 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-01-09